Alyeska Investment Group’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.06M | Hold |
290,092
| – | – | 0.02% | 421 |
|
|
2025
Q1 | $3.65M | Sell |
290,092
-963,632
| -77% | -$12.1M | 0.01% | 379 |
|
|
2024
Q4 | $13.2M | Buy |
1,253,724
+1,128,724
| +903% | +$11.9M | 0.05% | 307 |
|
|
2024
Q3 | $1.81M | Buy |
+125,000
| New | +$1.81M | 0.01% | 426 |
|
|
2021
Q2 | – | Sell |
-25,000
| Closed | -$1.09M | – | 819 |
|
|
2021
Q1 | $1.09M | Hold |
25,000
| – | – | 0.01% | 540 |
|
|
2020
Q4 | $1.16M | Buy |
+25,000
| New | +$1.16M | 0.02% | 402 |
|